• In vitro screening

  • Preclinical pharmacodynamic studies

  • Pharmacokinetic Services

  • Non-GLP safety assessment

ABOUT US

Sichuan XPiscoric Pharmaceutical Technology Co., Ltd. (XPiscoric Inc.) was registered in Chengdu Wenjiang Medical City in May 2016. We are a professional Contract Research Organization (CRO) specializing in preclinical new drug research. We provide customers with high-quality and efficient preclinical technical services for new drug development, including in vitro bioactivity screening, in vivo efficacy evaluation, pharmacokinetic (PK) studies, non-GLP safety assessment, clinical application services, and consultation. The company's core team members have extensive practical experience in innovative drug research and development. We stay abreast of the latest advances in research and development, providing customers with "one-stop" preclinical research technical services and solutions. The company currently has 5,000 square meters of facility space, including SPF and conventional animal facilities (for mice, rats, rabbits, dogs, monkeys, mini-pigs, etc.), a biochemistry laboratory, an electrophysiology lab, a bioanalytical laboratory, a test article management and preparation room, a BSL-2 cell biology laboratory, a microbiology laboratory, etc. Our standardized and comprehensive quality management system and project management processes support IND applications and on-site inspections by regulatory agencies. We have completed dozens of pharmacodynamic and pharmacokinetic studies to support IND submissions to the China NMPA and the US FDA. Equipped with UPS and a high-power diesel generator to ensure power supply, we have comprehensive data backup and storage measures.